Rudolph Hulspas

Ruud Hulspas is Technical Director of Process Development at Dana-Farber Cancer Institute. He is a Key Opinion Leader in cytometry with executive leadership experience and expertise in standards, quality, and controls in cell-based analytics. He is highly motivated to move commercial cell therapy forward through effective coordination between academic research, process development, CMC, and regulatory agencies. Ruud is a team leader capable of influencing through scientifically sound yet practical decisions. He earned his Ph.D. in Biology from the University of Amsterdam.